Figure 4
From: Structural basis for PPARγ transactivation by endocrine-disrupting organotin compounds
Cell-based transcriptional activation assay of rosiglitazone, TPT and TBT on wild-type, C285A and F363A mutants of PPARγ.
Data are expressed relative to the levels of vehicle-treated cells; these levels were set to 1. Results are expressed as means ± 1 S.D. of three independent cultures. *P < 0.05 indicates values significantly different between 2 groups analyzed by using 2-way ANOVA.
